T-Oncology AG is focusing on improving patients´ lifes and helping caregivers to have options in the treatment of cancer.
Our company works from a proprietary development platform to select small domain antibody fragments to develop drug conjugates to aim at well-known targets (HER2+), but also new ones. (Please inquire for more details)
Our initial mission is aiming at the unmet need to target brain metastasis from HER2+ lung, breast, bladder and colonrectal cancer.
We will not give up, for you to have an option and hope!
Company Details
T-Oncology Ag Questions
T-Oncology Ag's LinkedIn profile is https://ch.linkedin.com/company/t-oncology-ag
T-Oncology Ag has
3 employees.
View email and phone details for 3
employees at T-Oncology Ag.
T-Oncology Ag's industry is
Biotechnology Research
T-Oncology Ag's top competitors are
Blueclinical - An Astrum Company,
Jnana Therapeutics,
Ilonov,
Lxbio Pharmaceuticals,
Vectorb2b - Drug Development,
Amporin Pharmaceuticals,
Technophage, Sa,
Bluecallom Corp.,
Lxbio Antibody Discovery,
Selmod.
T-Oncology Ag's categories are Biotechnology Research
T-Oncology Ag's founding year is 2022
